+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07081880

Research on Genetic and Immune Factors in SAPHO Syndrome Studying Blood and DNA to Understand Disease Mechanisms

Led by Fondation Hôpital Saint-Joseph · Updated on 2025-12-24

100

Participants Needed

2

Research Sites

356 weeks

Total Duration

AI-Summary

What This Trial Is About

SAPHO syndrome is a chronic inflammatory condition involving bone or joint lesions and skin issues such as severe acne and pustulosis. It is a rare disease often misdiagnosed, with symptoms similar to other spondyloarthritis forms. This research focuses on understanding the genetic and immune response factors involved in SAPHO syndrome, aiming to clarify its complex causes and improve personalized treatment approaches. The study involves biological sampling, collecting DNA and cells from participants to analyze genetic predispositions and immune system characteristics. Researchers will examine the role of neutrophils and other immune cells in the development of SAPHO syndrome, including genetic studies across different populations. Assessments will include genetic and protein-level analyses at baseline and follow-up visits. Participants will provide blood samples at the start of the study and again at 6 months, with additional yearly follow-ups extending up to nine years. Researchers will study immune cell types, cytokine levels, and genetic variants to identify factors linked to disease severity and treatment response. The study also includes monitoring for genetic overlaps with other related conditions and aims to improve understanding of SAPHO syndromes biology over time.

CONDITIONS

Brief Title

Study of the Pathophysiological Mechanisms Involved in the SAPHO Syndrome: Genetic Component and Immune Response

Research Team

O

Olivier Fogel, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here